Ell P J, Hocknell J M, Jarritt P H, Cullum I, Lui D, Campos-Costa D, Nowotnik D P, Pickett R D, Canning L R, Neirinckx R D
Nucl Med Commun. 1985 Aug;6(8):437-41. doi: 10.1097/00006231-198508000-00002.
The first clinical data is given on 99Tcm-hexamethylpropyleneamine oxime (HM-PAO) in normal subjects and patients with established stroke. Regional cerebral blood flow maps (rCBF) have been recorded and displayed in tomographic mode with this new radiopharmaceutical. Good images were obtained, comparable to those achieved with 123I-isopropylamphetamine (IMP).
Zotero 插件